Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Neratinib Targets Vascular Inflammation in Atherosclerosis Models
January 2026
Neratinib markedly reduced vascular inflammation and atherosclerosis in mice by targeting ASK1, boosting effects with rosuvastatin.
Read more
26 Dec 2025
Locally Recurrent Rectal Cancer After Chemo Reirradiation
Neoadjuvant chemo-reirradiation alongside IOERT surgery produced manageable toxicity, and 75.7% two-year survival in patients with LRRC.
24 Dec 2025
Obesity, Sarcopenia, Host-Related Determinants of Immunotherapy Response in NSCLC
Host-related determinants of immunotherapy response in NSCLC hinge on body composition, metabolism, sex, and systemic inflammation.
21 Dec 2025
Dual Enrollment Strategy Supports Trial Diversity
An analysis confirms dual enrollment at private and safety-net hospitals is feasible for Phase I solid tumor trials, yielding higher diversity and similar patient survival rates.
20 Dec 2025
Cancer Clinical Trials Development in Latin America Lags
Cancer clinical trials development in Latin America underperforms globally yet strengths could expand equitable evidence worldwide.
20 Dec 2025
New Blood Test Detects Single Lung Cancer Cell
FT-IR microspectroscopy blood test detected a single circulating tumor cell in one patient with lung cancer, cytospun raw blood sample.
19 Dec 2025
Acupuncture, Massage Ease Symptoms in Underserved Patients with Cancer
Patients with cancer given access to free acupuncture and massage treatments at a community center in East Harlem, New York, reported symptom relief and broad satisfaction with services in an evaluation study.
17 Dec 2025
Male Circumcision Linked to Reduced Cervical Cancer Risk
Male circumcision is associated with lower odds of women developing various cervical lesions, according to a systematic review and meta-analysis.
14 Dec 2025
Public Insurance Linked To Poorer Breast Cancer Quality Of Life
Insurance coverage influences quality of life outcomes for women with early-stage estrogen receptor positive breast cancer.
Loading posts...
« Previous
1
2
3
4
…
31
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View